Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(25.0%)
N/A
1(25.0%)
Phase 2
1(25.0%)
Phase 1
1(25.0%)
4Total
Phase 3(1)
N/A(1)
Phase 2(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00160108Phase 1Completed

A Dietary Intervention- Randomized Controlled Trial (DIRECT) Study; BGU-Harvard-Robarts Collaboration

Role: lead

NCT00637858Not ApplicableTerminated

Effect of Different Doses of Tomato Lycopene on Blood Pressure in Pre-hypertensive Otherwise Healthy Subjects

Role: collaborator

NCT00480207Phase 2Completed

Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults

Role: collaborator

NCT00520182Phase 3Unknown

Dietary Interventions in Type 2 Obese Diabetic Patients in the Community

Role: collaborator

All 4 trials loaded